These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1094 related items for PubMed ID: 17284716

  • 1. Second cancer incidence and cause-specific mortality among 3104 patients with hairy cell leukemia: a population-based study.
    Hisada M, Chen BE, Jaffe ES, Travis LB.
    J Natl Cancer Inst; 2007 Feb 07; 99(3):215-22. PubMed ID: 17284716
    [Abstract] [Full Text] [Related]

  • 2. Risk of second malignant neoplasms after childhood leukemia and lymphoma: an international study.
    Maule M, Scélo G, Pastore G, Brennan P, Hemminki K, Tracey E, Sankila R, Weiderpass E, Olsen JH, McBride ML, Brewster DH, Pompe-Kirn V, Kliewer EV, Chia KS, Tonita JM, Martos C, Jonasson JG, Merletti F, Boffetta P.
    J Natl Cancer Inst; 2007 May 16; 99(10):790-800. PubMed ID: 17505074
    [Abstract] [Full Text] [Related]

  • 3. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
    Huang KP, Weinstock MA, Clarke CA, McMillan A, Hoppe RT, Kim YH.
    Arch Dermatol; 2007 Jan 16; 143(1):45-50. PubMed ID: 17224541
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Risk of second benign brain tumors among cancer survivors in the surveillance, epidemiology, and end results program.
    Kutsenko A, Berrington de Gonzalez A, Curtis RE, Rajaraman P.
    Cancer Causes Control; 2014 Jun 16; 25(6):659-68. PubMed ID: 24682745
    [Abstract] [Full Text] [Related]

  • 6. Merkel cell carcinoma: incidence, mortality, and risk of other cancers.
    Kaae J, Hansen AV, Biggar RJ, Boyd HA, Moore PS, Wohlfahrt J, Melbye M.
    J Natl Cancer Inst; 2010 Jun 02; 102(11):793-801. PubMed ID: 20424236
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Use of Radioactive Iodine for Thyroid Cancer and Risk of Second Primary Malignancy: A Nationwide Population-Based Study.
    Teng CJ, Hu YW, Chen SC, Yeh CM, Chiang HL, Chen TJ, Liu CJ.
    J Natl Cancer Inst; 2016 Feb 02; 108(2):. PubMed ID: 26538627
    [Abstract] [Full Text] [Related]

  • 11. Subsequent primary cancers among men and women with in situ and invasive melanoma of the skin.
    Balamurugan A, Rees JR, Kosary C, Rim SH, Li J, Stewart SL.
    J Am Acad Dermatol; 2011 Nov 02; 65(5 Suppl 1):S69-77. PubMed ID: 22018070
    [Abstract] [Full Text] [Related]

  • 12. Second cancers among 40,576 testicular cancer patients: focus on long-term survivors.
    Travis LB, Fosså SD, Schonfeld SJ, McMaster ML, Lynch CF, Storm H, Hall P, Holowaty E, Andersen A, Pukkala E, Andersson M, Kaijser M, Gospodarowicz M, Joensuu T, Cohen RJ, Boice JD, Dores GM, Gilbert ES.
    J Natl Cancer Inst; 2005 Sep 21; 97(18):1354-65. PubMed ID: 16174857
    [Abstract] [Full Text] [Related]

  • 13. Second Primary Malignancies in Mantle Cell Lymphoma: A US Population-based Study.
    Shah BK, Khanal A.
    Anticancer Res; 2015 Jun 21; 35(6):3437-40. PubMed ID: 26026107
    [Abstract] [Full Text] [Related]

  • 14. Risk of second cancer after treatment of aggressive non-Hodgkin's lymphoma; an EORTC cohort study.
    Moser EC, Noordijk EM, van Leeuwen FE, Baars JW, Thomas J, Carde P, Meerwaldt JH, van Glabbeke M, Kluin-Nelemans HC.
    Haematologica; 2006 Nov 21; 91(11):1481-8. PubMed ID: 17043014
    [Abstract] [Full Text] [Related]

  • 15. Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up.
    Marees T, Moll AC, Imhof SM, de Boer MR, Ringens PJ, van Leeuwen FE.
    J Natl Cancer Inst; 2008 Dec 17; 100(24):1771-9. PubMed ID: 19066271
    [Abstract] [Full Text] [Related]

  • 16. Risk for malignancies of infectious etiology among adult survivors of specific non-Hodgkin lymphoma subtypes.
    Herr MM, Schonfeld SJ, Dores GM, Engels EA, Tucker MA, Curtis RE, Morton LM.
    Blood Adv; 2019 Jul 09; 3(13):1961-1969. PubMed ID: 31262739
    [Abstract] [Full Text] [Related]

  • 17. Risk of a second malignant neoplasm among 5-year survivors of cancer in childhood and adolescence in British Columbia, Canada.
    MacArthur AC, Spinelli JJ, Rogers PC, Goddard KJ, Phillips N, McBride ML.
    Pediatr Blood Cancer; 2007 Apr 09; 48(4):453-9. PubMed ID: 16767718
    [Abstract] [Full Text] [Related]

  • 18. Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma.
    Travis LB, Hill D, Dores GM, Gospodarowicz M, van Leeuwen FE, Holowaty E, Glimelius B, Andersson M, Pukkala E, Lynch CF, Pee D, Smith SA, Van't Veer MB, Joensuu T, Storm H, Stovall M, Boice JD, Gilbert E, Gail MH.
    J Natl Cancer Inst; 2005 Oct 05; 97(19):1428-37. PubMed ID: 16204692
    [Abstract] [Full Text] [Related]

  • 19. Long-term cause-specific mortality in survivors of adolescent and young adult bone and soft tissue sarcoma: a population-based study of 28,844 patients.
    Youn P, Milano MT, Constine LS, Travis LB.
    Cancer; 2014 Aug 01; 120(15):2334-42. PubMed ID: 24752471
    [Abstract] [Full Text] [Related]

  • 20. Mutual Risks of Cutaneous Melanoma and Specific Lymphoid Neoplasms: Second Cancer Occurrence and Survival.
    Herr MM, Schonfeld SJ, Dores GM, Withrow DR, Tucker MA, Curtis RE, Morton LM.
    J Natl Cancer Inst; 2018 Nov 01; 110(11):1248-1258. PubMed ID: 29659938
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 55.